Delivery Order SPE2DB24D1007-SPE2DB25FCDCX
- Not listed
- The Defense Logistics Agency awarded a $1,664.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 60 mg on September 8, 2025, with completion scheduled for September 9, 2025. This contract is classified as firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,534.28 for 60 mg Brilinta tablets (60-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,234.42 for Brilinta 90 mg tablets (60-count units) with a firm fixed price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Brilinta 90 mg tablets (60-count units) at a ceiling value of $4,019.96. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The order is scheduled for completion by August 28, 2025, with the place of performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,847.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count). The contract, which is not set-aside and competitively awarded, is scheduled for completion by July 21, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Brilinta 90 mg tablets (60-count units) valued at $3,168.70 under a firm fixed price contract. This delivery order was competitively awarded without set-aside designation and is set to be completed by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BRILINTA 60 mg tablets (60-count units) with a ceiling value of $2,852.60. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The contract involves no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on August 5, 2025, with a ceiling value of $1,468.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,167.73. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCDCXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Brilinta 60 mg tablets (60-count) with a ceiling value of $4,881.64. This non-competitive delivery order, which is firm fixed price in nature, represents a single pharmaceutical procurement supporting military and federal healthcare operations. The contract is classified as a child award issued under a larger indefinite delivery vehicle and is scheduled for ultimate completion by September 9, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of medications and medical supplies to support military healthcare systems globally. The company's federal contracting demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains, positioning it as a critical supplier for Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/8/25 |